Lori Lofaro

511 total citations
17 papers, 188 citations indexed

About

Lori Lofaro is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Lori Lofaro has authored 17 papers receiving a total of 188 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 4 papers in Surgery and 3 papers in Oncology. Recurrent topics in Lori Lofaro's work include Lung Cancer Diagnosis and Treatment (13 papers), Lung Cancer Treatments and Mutations (10 papers) and Tracheal and airway disorders (4 papers). Lori Lofaro is often cited by papers focused on Lung Cancer Diagnosis and Treatment (13 papers), Lung Cancer Treatments and Mutations (10 papers) and Tracheal and airway disorders (4 papers). Lori Lofaro collaborates with scholars based in United States and United Kingdom. Lori Lofaro's co-authors include Giulia C. Kennedy, Jing Huang, Dennis L. Broyles, Yoonha Choi, Lonny Yarmus, Carly J. Paoli, William J. Harmon, Ronald Tutrone, Daniel R. Saltzstein and B. Vittal Shenoy and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and CHEST Journal.

In The Last Decade

Lori Lofaro

16 papers receiving 178 citations

Peers

Countries citing papers authored by Lori Lofaro

Since Specialization

Citations

This map shows the geographic impact of Lori Lofaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori Lofaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori Lofaro more than expected).

Fields of papers citing papers by Lori Lofaro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori Lofaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori Lofaro. The network helps show where Lori Lofaro may publish in the future.

Co-authorship network of co-authors of Lori Lofaro

This figure shows the co-authorship network connecting the top 25 collaborators of Lori Lofaro. A scholar is included among the top collaborators of Lori Lofaro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori Lofaro. Lori Lofaro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	A Nasal Swab Classifier to Evaluate the Probability of Lung Cancer in Patients With Pulmonary Nodules 2023 ·CHEST Journal ·Carla Lamb, Kimberly Rieger‐Christ, Chakravarthy Reddy, Jing Huang, (unknown), Marla Johnson, P. Sean Walsh, William A. Bulman, Lori Lofaro, Momen M. Wahidi, David Feller‐Kopman, Avrum Spira, Giulia C. Kennedy, Peter J. Mazzone	3
2	Reclassification of risk of malignancy with Percepta Genomic Sequencing Classifier following nondiagnostic bronchoscopy 2022 ·Respiratory Medicine ·(unknown), Bryan S. Benn, Sadia Benzaquen, (unknown), Marla Johnson, Jing Huang, Lori Lofaro, (unknown), (unknown), Giulia C. Kennedy, William A. Bulman, Jonathan S. Kurman	3
3	Clinical validation and utility of Percepta GSC for the evaluation of lung cancer 2022 ·PLoS ONE ·Peter J. Mazzone, (unknown), Momen M. Wahidi, Michael Bernstein, Hans J. Lee, (unknown), Lonny Yarmus, Duncan Whitney, Christopher S. Stevenson, Jianghan Qu, Marla Johnson, P. Sean Walsh, Jing Huang, Lori Lofaro, Sangeeta Bhorade, Giulia C. Kennedy, Avrum Spira, M. Patricia Rivera, (unknown), (unknown)	6
4	Percepta Genomic Sequencing Classifier and decision-making in patients with high-risk lung nodules: a decision impact study 2022 ·BMC Pulmonary Medicine ·Sonali Sethi, Scott Oh, Alexander Chen, Christina Bellinger, Lori Lofaro, Marla Johnson, Jing Huang, Sangeeta Bhorade, William A. Bulman, Giulia C. Kennedy	6
5	Comparing modalities for risk assessment in patients with pulmonary lesions and nondiagnostic bronchoscopy for suspected lung cancer 2022 ·BMC Pulmonary Medicine ·Diana Yu, Mājid Shafiq, Hitesh Batra, Marla Johnson, (unknown), (unknown), Lori Lofaro, Jing Huang, William A. Bulman, Giulia C. Kennedy, Lonny Yarmus, Hans J. Lee, David Feller‐Kopman	2
6	A Nasal Genomic Classifier for Assessing Risk of Malignancy in Lung Nodules Demonstrates Similar Performance in Patients That Meet Screening Criteria for High Baseline Risk and Those Who Do Not 2022 ·Carla Lamb, Kimberly Rieger‐Christ, C. R. R. M. Reddy, Jing Huang, (unknown), (unknown), P. Sean Walsh, J Wilde, Sangeeta Bhorade, William A. Bulman, Lori Lofaro, Momen M. Wahidi, David Feller‐Kopman, (unknown), Gwen Kennedy, Peter J. Mazzone	1
7	Analytical validation of the Percepta genomic sequencing classifier; an RNA next generation sequencing assay for the assessment of Lung Cancer risk of suspicious pulmonary nodules 2021 ·BMC Cancer ·Marla Johnson, (unknown), Daniel G. Pankratz, Grazyna Fedorowicz, (unknown), (unknown), (unknown), Manqiu Cao, Joshua Babiarz, Lori Lofaro, P. Sean Walsh, Giulia C. Kennedy, Jing Huang	5
8	A NASAL CLINICAL-GENOMIC CLASSIFIER FOR ASSESSING RISK OF MALIGNANCY IN LUNG NODULES DEMONSTRATES ACCURATE PERFORMANCE INDEPENDENT OF NODULE SIZE OR CANCER STAGE 2021 ·CHEST Journal ·Carla Lamb, Kimberly Rieger‐Christ, Chakravarthy Reddy, (unknown), Jianghan Qu, (unknown), Marla Johnson, Duncan Whitney, P. Sean Walsh, Jonathan I. Wilde, Sangeeta Bhorade, William A. Bulman, Lori Lofaro, Jing Huang, Avi Spira, Giulia C. Kennedy, Peter J. Mazzone	2
9	Early candidate nasal swab classifiers developed using machine learning and whole transcriptome sequencing may improve early lung cancer detection. 2021 ·Journal of Clinical Oncology ·Peter J. Mazzone, Carla Lamb, Kimberly Rieger‐Christ, Chakravarthy B. Reddy, Jianghan Qu, (unknown), (unknown), Duncan Whitney, Daniel G. Pankratz, Joshua Babiarz, Lori Lofaro, P. Sean Walsh, J Wilde, Sangeeta Bhorade, Jing Huang, Giulia C. Kennedy, Avrum Spira	3
10	The impact of a genomic sequencing classifier (GSC) on clinical decision making in patients with a high-risk lung nodule. 2021 ·Journal of Clinical Oncology ·Sonali Sethi, Scott Oh, (unknown), Christina Bellinger, Lori Lofaro, Jennifer Tom, Marla Johnson, Jing Huang, Sangeeta Bhorade, Giulia C. Kennedy	1
11	Detection of actionable molecular alterations through combined DNA/RNA molecular profiling of biopsies collected in early-stage lung cancer at time of diagnosis. 2021 ·Journal of Clinical Oncology ·Joshua Babiarz, Yangyang Hao, Manqiu Cao, (unknown), David S. Wilson, William Krimsky, Saiyad Sarkar, Michael A. Bernstein, Hans C. Lee, Momen M. Wahidi, Alexander Chen, Christina Bellinger, Lori Lofaro, Sangeeta Bhorade, Jing Huang, P. Sean Walsh, Jonathan I. Wilde, Giulia C. Kennedy	1
12	Impact of the Percepta Genomic Classifier on Clinical Management Decisions in a Multicenter Prospective Study 2020 ·CHEST Journal ·Hans J. Lee, Peter J. Mazzone, David Feller‐Kopman, Lonny Yarmus, Kyle Hogarth, Lori Lofaro, (unknown), Marla Johnson, Yoonha Choi, Jing Huang, Sangeeta Bhorade, Avrum Spira, Giulia C. Kennedy, Momen M. Wahidi	16
13	An Evaluation of Diagnostic Yield From Bronchoscopy 2020 ·CHEST Journal ·Gerard A. Silvestri, (unknown), Jing Huang, (unknown), Yoonha Choi, Giulia C. Kennedy, Lori Lofaro, Alex Chen, M. Patricia Rivera, Nichole T. Tanner, Anil Vachani, Lonny Yarmus, Nicholas J. Pastis	43
14	Improving lung cancer risk stratification leveraging whole transcriptome RNA sequencing and machine learning across multiple cohorts 2020 ·BMC Medical Genomics ·Yoonha Choi, Jianghan Qu, (unknown), Yangyang Hao, (unknown), Jianchang Ning, Xinwu Yang, Lori Lofaro, Daniel G. Pankratz, Joshua Babiarz, P. Sean Walsh, Ehab Billatos, Marc E. Lenburg, Giulia C. Kennedy, Jon McAuliffe, Jing Huang	17
15	OUTCOMES OF ATYPICAL CELLS ON BRONCHOSCOPY FOR MALIGNANCY 2019 ·CHEST Journal ·(unknown), Jeffrey Thiboutot, Christopher Mallow, Mājid Shafiq, Lonny Yarmus, David Feller‐Kopman, (unknown), Lori Lofaro, Hans C. Lee	1
16	Multi-center clinical evaluation of the Access AMH assay to determine AMH levels in reproductive age women during normal menstrual cycles 2018 ·Journal of Assisted Reproduction and Genetics ·Clarisa R. Gracia, Sanghyuk S. Shin, Maureen Prewitt, (unknown), Lori Lofaro, (unknown), (unknown), (unknown), Dennis L. Broyles	31
17	Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting 2017 ·Prostate Cancer and Prostatic Diseases ·(unknown), B. Vittal Shenoy, Ronald Tutrone, Lawrence I. Karsh, Daniel R. Saltzstein, William J. Harmon, Dennis L. Broyles, (unknown), Lori Lofaro, Carly J. Paoli, (unknown), Mark A. Reynolds	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact